Sartorius acquires WaterSep BioSeparations

By The Science Advisory Board staff writers

December 11, 2020 -- Sartorius Stedim Biotech has acquired WaterSep BioSeparations for approximately $27 million plus an earn-out based on sales revenues through 2023 of up to $9 million. The transaction adds to Sartorius' filtration units for bioprocessing devices.

WaterSep BioSeparations is a privately owned company based in Malborough, MA, which employs 15 people and is on track to earn revenue of approximately $2.5 million in 2020. The company develops, manufactures, and markets hollow-fiber membrane devices (crossflow filtration) and presterilized assemblies for upstream and downstream biopharmaceutical applications.
Sartorius expands small sample filtration to 50mL
The new Sartolab RF 50 vacuum filtration units are available in two versions, one with an asymmetric 0.22 µm PES membrane for sterile filtration...

Copyright © 2020

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter